deepeye
deepeye is a treatment of age-related macular degeneration (AMD founded in 2021.
1
Funding Rounds
$2.7m
Money raised
Overview
deepeye is a treatment of age-related macular degeneration (AMD founded in 2021.
- Websites:
- Business model: B2C
- Headquarters: Munich
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company deepeye has raised a total of $2.7m in funding over 1 rounds.
Key Insights:
- Deepeye November 2023 Seed Funding Round: $2.7m
Deepeye November 2023 Seed Funding Round
$2.7m
Industries
deepeye is active in the following industries: